Atypical chronic myelogenous leukemia following immunosuppressive therapy for severe aplastic anemia

Citation
T. Robak et al., Atypical chronic myelogenous leukemia following immunosuppressive therapy for severe aplastic anemia, LEUK LYMPH, 35(1-2), 1999, pp. 193
Citations number
24
Categorie Soggetti
Hematology,"Onconogenesis & Cancer Research
Journal title
LEUKEMIA & LYMPHOMA
ISSN journal
10428194 → ACNP
Volume
35
Issue
1-2
Year of publication
1999
Database
ISI
SICI code
1042-8194(199909)35:1-2<193:ACMLFI>2.0.ZU;2-W
Abstract
Late clonal complications of aplastic anemia (AA) such as acute leukemia, m yelodysplastic syndromes or paroxysmal nocturnal hemoglobinuria have been r ecognized for a long time. To our knowledge, chronic myelogenous leukemia ( CML) as a late complication of severe aplastic anemia has as yet not been r eported. We report here a case of AA treated successfully with antilymphocy tic globulin and cyclosporin in whom Ph-1 negative, BCR/ABL negative CML de veloped 8 years after diagnosis of AA. This case of atypical, secondary CML was refractory to treatment with interferon a and hydroxyurea.